Senseonics (NYSE:SENS) announced today that its Eversense NOW remote monitoring app for Android received CE mark approval.
Germantown, Maryland-based Senseonics already received such approval for the Eversense NOW iOS platform and can now offer it in Europe on the Android operating system. The company expects to make the Eversense NOW remote monitoring app for Android available in the first quarter of 2022 on the Google Play Store.
Eversense NOW offers real-time glucose data and alerts in tandem with the Eversense XL continuous glucose monitoring (CGM) system that measures glucose levels in persons 18 years of age and older with diabetes for up to 180 days. Senseonics designed the system to complement, not replace, fingersticks.
Data presented earlier this year demonstrated strong accuracy, with the next-generation Eversense matching performance levels compared to the current 90-day sensor available in the U.S., but with reduced calibration, down to one per day, with duration extended to 180 days.
“We’re pleased to offer yet another tool for our Eversense users in Europe, now enabling access to this important feature for all our customers,” Senseonics President & CEO Tim Goodnow said in a news release. “With the Eversense NOW app, Eversense users can enjoy the added peace of mind that comes with knowing friends and family can remotely view real-time glucose data, see trend graphs, and receive real-time glucose alerts from anywhere.”